High-specificity affinity reagents for the detection of glycan sialylation

用于检测聚糖唾液酸化的高特异性亲和试剂

基本信息

  • 批准号:
    8832864
  • 负责人:
  • 金额:
    $ 34.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-01-15 至 2016-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Glycans have several distinct properties that make their development as disease biomarkers appealing. Firstly, their location on cell surfaces makes them the first point of contact for cellular interactions, and thus they are crucial in the control of normal metabolic processes, and conversely, they function as pathogen adhesion receptors. Secondly, specific glycan structures that are not present, or are in low amounts in normal state, proliferate or alter their sequence in disease states. And, lastly, changes in glycosylation may be found in many proteins, including those that are highly abundant. Thus changes in the normal levels of glycan structures, such as terminal sialic acid, may be markers of disease states. New highly-specific reagents are required in order to overcome current limitations in the discovery and exploitation of disease-related glycans. Using structurally-guided genetic manipulations, we will convert the NanB sialidase from S. pneumococcus into a high-specificity affinity reagent for the detection of sialic acid modifications of glycopeptides and glycoproteins. Because such a protein has lectin-like properties, but is derived from an enzyme, it is called a "Lectenz(r)". A NanB Lectenz(r) addresses a key need in disease glycomarker detection: namely, a robust and easy to produce reagent specific for �3-linked sialic acid. This reagent could be employed in an affinity matrix for sample enrichment, which in conjunction with existing MS based methods could provide linkage information. It could also be employed in histological studies, or Western blots, etc. Lectenz(r) offer numerous advantages over plant lectins: they are engineered to be high affinity and yet retain the exquisite substrate specificityof the endogenous enzyme, they may be efficiently produced, and for human homologues have the potential to be employed in vivo with low toxicity. Whereas some aspects of Lectenz(r) development parallel those of antibody evolution, Lectenz(r) have the tremendous benefit of employing a protein naive template that has the desired specificity.
描述(申请人提供):葡聚糖具有几种独特的性质,使其作为疾病生物标记物的开发具有吸引力。首先,它们在细胞表面的位置使它们成为细胞相互作用的第一个接触点,因此它们在控制正常的代谢过程中起着至关重要的作用,反过来,它们也作为病原体黏附受体发挥作用。其次,特定的糖链结构不存在,或在正常状态下数量较少,在疾病状态下会增殖或改变其序列。最后,在许多蛋白质中可能会发现糖基化的变化,包括那些高度丰富的蛋白质。因此,糖链结构的正常水平的变化,如末端唾液酸,可能是疾病状态的标志。为了克服目前在发现和开发与疾病相关的多糖方面的限制,需要新的高度特异的试剂。使用结构指导的 通过基因操作,我们将肺炎链球菌的纳米B唾液酸酶转化为高特异性亲和试剂,用于检测糖肽和糖蛋白的唾液酸修饰。因为这种蛋白质具有类似凝集素的性质,但它是从一种酶中提取的,所以它被称为“Lectenz(R)”。NanB Lectenz(R)解决了疾病糖标记物检测中的一个关键需求:即一种强大且易于生产的专用于�3连接的唾液酸的试剂。该试剂可用于样品浓缩的亲和矩阵中,与现有的基于MS的方法相结合可提供连锁信息。它还可以用于组织学研究或蛋白质印迹等。与植物凝集素相比,Lectenz(R)具有许多优势:它们经过精心设计,具有高亲和力,同时保留了精致的底物专一性,可以有效地产生内源性酶,并且对于人类同源物来说,具有低毒用于体内的潜力。虽然Lectenz(R)发展的某些方面与抗体进化类似,但Lectenz(R)使用具有所需特异性的蛋白质朴素模板具有巨大的好处。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Loretta Yang其他文献

Loretta Yang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Loretta Yang', 18)}}的其他基金

A new approach to monitoring glycosylation during glycoprotein production
监测糖蛋白生产过程中糖基化的新方法
  • 批准号:
    10830193
  • 财政年份:
    2023
  • 资助金额:
    $ 34.89万
  • 项目类别:
Development of a suite of high-specificity fucose binding reagents
一套高特异性岩藻糖结合试剂的开发
  • 批准号:
    10084298
  • 财政年份:
    2020
  • 资助金额:
    $ 34.89万
  • 项目类别:
Development of a suite of high-specificity fucose binding reagents
一套高特异性岩藻糖结合试剂的开发
  • 批准号:
    9909159
  • 财政年份:
    2020
  • 资助金额:
    $ 34.89万
  • 项目类别:
A rapid method for monitoring in vitro glycoengineering
一种快速监测体外糖工程的方法
  • 批准号:
    9346470
  • 财政年份:
    2017
  • 资助金额:
    $ 34.89万
  • 项目类别:
High-specificity affinity reagents for the detection of glycan sialylation
用于检测聚糖唾液酸化的高特异性亲和试剂
  • 批准号:
    8994739
  • 财政年份:
    2015
  • 资助金额:
    $ 34.89万
  • 项目类别:
In-process glycoprofiling during recombinant therapeutic glycoprotein production
重组治疗性糖蛋白生产过程中的糖谱分析
  • 批准号:
    8253195
  • 财政年份:
    2012
  • 资助金额:
    $ 34.89万
  • 项目类别:

相似海外基金

Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
  • 批准号:
    10549640
  • 财政年份:
    2023
  • 资助金额:
    $ 34.89万
  • 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
  • 批准号:
    2750554
  • 财政年份:
    2021
  • 资助金额:
    $ 34.89万
  • 项目类别:
    Studentship
Affinity Biosensors for COVID-19 Antibodies
适用于 COVID-19 抗体的亲和生物传感器
  • 批准号:
    61319
  • 财政年份:
    2020
  • 资助金额:
    $ 34.89万
  • 项目类别:
    Feasibility Studies
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10013588
  • 财政年份:
    2020
  • 资助金额:
    $ 34.89万
  • 项目类别:
Affinity maturation and property changes of single-domain antibodies through repeated immunizations.
通过重复免疫,单域抗体的亲和力成熟和性质变化。
  • 批准号:
    20K07009
  • 财政年份:
    2020
  • 资助金额:
    $ 34.89万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性:旨在实现抗体的全面计算机设计
  • 批准号:
    10603473
  • 财政年份:
    2020
  • 资助金额:
    $ 34.89万
  • 项目类别:
IN SILICO DESIGN OF HIGH-AFFINITY RECOMBINANT ANTIBODIES
高亲和力重组抗体的计算机模拟设计
  • 批准号:
    2342674
  • 财政年份:
    2020
  • 资助金额:
    $ 34.89万
  • 项目类别:
    Studentship
Strategies for generating high affinity antibodies against Gram negative bacteria
产生针对革兰氏阴性菌的高亲和力抗体的策略
  • 批准号:
    10117194
  • 财政年份:
    2020
  • 资助金额:
    $ 34.89万
  • 项目类别:
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10115604
  • 财政年份:
    2020
  • 资助金额:
    $ 34.89万
  • 项目类别:
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
跨学科蛋白质工程方法设计黄病毒高亲和力抗体
  • 批准号:
    10294224
  • 财政年份:
    2018
  • 资助金额:
    $ 34.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了